Literature DB >> 24636438

Bullous pemphigoid associated with acquired hemophilia a: a rare association of autoimmune disease.

Mohammed I Aljasser, Chris Sladden, Richard I Crawford, Sheila Au.   

Abstract

BACKGROUND: Acquired hemophilia (AH) is a rare autoimmune disease with an annual incidence of one per million and has a mortality rate of up to 22%. It is caused by the development of autoantibodies against factor VIII. Approximately half of the reported cases are associated with autoimmune disorders, pregnancy, malignancies, and adverse drug reactions. Autoimmune diseases are the most frequently associated disorders and include rheumatoid arthritis, systemic lupus erythematosus, cryoglobulinemia, pemphigus vulgaris, and bullous pemphigoid. There are a few reports of acquired hemophilia and bullous pemphigoid in the literature.
METHOD: We report a 73-year-old male who presented with cutaneous blistering, upper gastrointestinal bleeding, and hemoptysis. He later developed right flank pain secondary to a retroperitoneal hematoma. He had a prolonged partial thromboplastin time, a low factor VIII level, and a high factor VIII inhibitor level, all consistent with acquired hemophilia. Skin biopsies were diagnostic for bullous pemphigoid.
RESULTS: He was treated successfully with prednisone, cyclophosphamide, rituximab, and intravenous immunoglobulin.

Entities:  

Mesh:

Year:  2014        PMID: 24636438     DOI: 10.2310/7750.2013.13060

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  5 in total

Review 1.  Rituximab for eradicating inhibitors in people with acquired haemophilia A.

Authors:  Tracey Remmington; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

2.  Immunoglobulin G4-related acquired hemophilia: A case report.

Authors:  Xiaoyan Li; Wei Duan; Xiang Zhu; Jianying Xu
Journal:  Exp Ther Med       Date:  2016-11-14       Impact factor: 2.447

3.  Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature.

Authors:  Quentin Binet; Catherine Lambert; Laurine Sacré; Stéphane Eeckhoudt; Cedric Hermans
Journal:  Case Rep Hematol       Date:  2017-03-28

4.  Bullous Pemphigoid Associated with Acquired Hemophilia A: A Case Report and Review of the Literature.

Authors:  Wuttidej Fakprapai; Penpun Wattanakrai
Journal:  Case Rep Dermatol       Date:  2019-05-21

5.  Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review.

Authors:  Peng Cao; Wenjing Xu; Litao Zhang
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.